{
    "2021-11-17": [
        [
            {
                "time": "2021-11-05",
                "original_text": "Stocks: Travel and crypto dip, retail rallies, pharmaceuticals rise",
                "features": {
                    "keywords": [
                        "travel",
                        "crypto",
                        "retail",
                        "pharmaceuticals"
                    ],
                    "sentiment_score": 0.2,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "travel",
                        "cryptocurrency",
                        "retail",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "Pfizer (PFE) Seeks FDA's Emergency Use Nod for COVID Pill",
                "features": {
                    "keywords": [
                        "Pfizer",
                        "FDA",
                        "COVID",
                        "pill"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "Lilly to Participate in Fourth Annual Evercore ISI HealthCONx Conference",
                "features": {
                    "keywords": [
                        "Lilly",
                        "Evercore",
                        "ISI",
                        "HealthCONx",
                        "Conference"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "3 Big Pharma Outperformers to Watch Out For in the Near Term",
                "features": {
                    "keywords": [
                        "Big",
                        "Pharma",
                        "Outperformers",
                        "Near",
                        "Term"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "Glaxo and Vir Report $1 Billion Sale of Covid-19 Antibody. The U.S. Is Still Buying.",
                "features": {
                    "keywords": [
                        "Glaxo",
                        "Vir",
                        "Covid-19",
                        "Antibody",
                        "U.S."
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-11-05",
                "original_text": "Could Eli Lilly Leapfrog Biogen in This Market?",
                "features": {
                    "keywords": [
                        "Eli",
                        "Lilly",
                        "Leapfrog",
                        "Biogen",
                        "Market"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}